A Computational Model for Docking of Noncompetitive Neuraminidase Inhibitors and Probing their Binding Interactions with Neuraminidase of Influenza Virus H5N1

By  

Current Computer - Aided Drug Design, Vol. 12, Iss. 4, 2016-12 ,pp. : 272-281

Bentham Science Publishers

Access to resources Recommend Favorite

Oseltamivir/zanamivir: Development of neuraminidase inhibitor resistance in influenza A virus H1N1 subtype in a child: case report

By  

Reactions Weekly, Vol. 1, Iss. 1326, 2010-01 ,pp. : 26-27

Adis International

Access to resources Recommend Favorite

Drugs Against Avian Influenza A Virus: Design of Novel Sulfonate Inhibitors of Neuraminidase N1

By  

Current Pharmaceutical Design, Vol. 20, Iss. 21, 2014-05 ,pp. : 3478-3487

Bentham Science Publishers

Access to resources Recommend Favorite

Binding Mechanism of H5N1 Influenza Virus Neuraminidase with Ligands and its Implication for Drug Design

By  

Medicinal Chemistry, Vol. 5, Iss. 3, 2009-05 ,pp. : 242-249

Bentham Science Publishers

Access to resources Recommend Favorite

Revision of QSAR, Docking, and Molecular Modeling Studies of Anti-Influenza Virus A (H1N1) Drugs and Targets: Analysis of Hemagglutinins 3D Structure

By  

Current Computer - Aided Drug Design, Vol. 7, Iss. 4, 2011-01 ,pp. : 255-262

Bentham Science Publishers

Access to resources Recommend Favorite